Cargando…

Impaired Glucagon-Mediated Suppression of VLDL-Triglyceride Secretion in Individuals With Metabolic Dysfunction–Associated Fatty Liver Disease (MAFLD)

Individuals with metabolic dysfunction–associated fatty liver disease (MAFLD) have elevated plasma lipids as well as glucagon, although glucagon suppresses hepatic VLDL-triglyceride (TG) secretion. We hypothesize that the sensitivity to glucagon in hepatic lipid metabolism is impaired in MAFLD. We r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Heebøll, Sara, Risikesan, Jeyanthini, Ringgaard, Steffen, Kumarathas, Indumathi, Sandahl, Thomas D., Grønbæk, Henning, Søndergaard, Esben, Nielsen, Søren
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2022
Materias:	Pathophysiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9630084/ https://www.ncbi.nlm.nih.gov/pubmed/36001750 http://dx.doi.org/10.2337/db22-0313

Ejemplares similares

Increased VLDL-Triglyceride Secretion Precedes Impaired Control of Endogenous Glucose Production in Obese, Normoglycemic Men
por: Sørensen, Lars P., et al.
Publicado: (2011)

Basal and Insulin Mediated VLDL-Triglyceride Kinetics in Type 2 Diabetic Men
por: Sørensen, Lars P., et al.
Publicado: (2011)

Loss of Inverse Relationship Between Pulsatile Insulin and Glucagon Secretion in Patients With Type 2 Diabetes
por: Menge, Björn A., et al.
Publicado: (2011)

Rapid Tachyphylaxis of the Glucagon-Like Peptide 1–Induced Deceleration of Gastric Emptying in Humans
por: Nauck, Michael A., et al.
Publicado: (2011)

Intramyocellular Triglyceride Content During the Early Course of Type 1 and Type 2 Diabetes
por: Schön, Martin, et al.
Publicado: (2023)

Protein Engineering Strategies for Sustained Glucagon-Like Peptide-1 Receptor–Dependent Control of Glucose Homeostasis
por: Picha, Kristen M., et al.
Publicado: (2008)

The Glucagonostatic and Insulinotropic Effects of Glucagon-Like Peptide 1 Contribute Equally to Its Glucose-Lowering Action
por: Hare, Kristine J., et al.
Publicado: (2010)

Skeletal Muscle Triglycerides, Diacylglycerols, and Ceramides in Insulin Resistance: Another Paradox in Endurance-Trained Athletes?
por: Amati, Francesca, et al.
Publicado: (2011)

Glucagon-Like Peptide 1 Recruits Muscle Microvasculature and Improves Insulin’s Metabolic Action in the Presence of Insulin Resistance
por: Chai, Weidong, et al.
Publicado: (2014)

Evidence Against an Important Role of Plasma Insulin and Glucagon Concentrations in the Increase in EGP Caused by SGLT2 Inhibitors
por: Alatrach, Mariam, et al.
Publicado: (2020)

Glucagon-Like Peptide 1 Recruits Microvasculature and Increases Glucose Use in Muscle via a Nitric Oxide–Dependent Mechanism
por: Chai, Weidong, et al.
Publicado: (2012)

Glucagon-Like Peptide 1 Receptor Activation Augments Cardiac Output and Improves Cardiac Efficiency in Obese Swine After Myocardial Infarction
por: Sassoon, Daniel J., et al.
Publicado: (2017)

N-Glycosylation of Carnosinase Influences Protein Secretion and Enzyme Activity: Implications for Hyperglycemia
por: Riedl, Eva, et al.
Publicado: (2010)

Adiponectin Reduces Plasma Triglyceride by Increasing VLDL Triglyceride Catabolism
por: Qiao, Liping, et al.
Publicado: (2008)

The Role of Endogenous Incretin Secretion as Amplifier of Glucose-Stimulated Insulin Secretion in Healthy Subjects and Patients With Type 2 Diabetes
por: Woerle, Hans Juergen, et al.
Publicado: (2012)

Similar VLDL-TG Storage in Visceral and Subcutaneous Fat in Obese and Lean Women
por: Søndergaard, Esben, et al.
Publicado: (2011)

Preserved glucagon-like peptide-1 responses to oral glucose, but reduced incretin effect, insulin secretion and sensitivity in young Asians with type 2 diabetes mellitus
por: Yeow, Toh Peng, et al.
Publicado: (2017)

No effect of 10 weeks erythropoietin treatment on lipid oxidation in healthy men
por: Risikesan, Jeyanthini, et al.
Publicado: (2020)

Sitagliptin, a DPP-4 Inhibitor, Acutely Inhibits Intestinal Lipoprotein Particle Secretion in Healthy Humans
por: Xiao, Changting, et al.
Publicado: (2014)

Na(+)-d-glucose Cotransporter SGLT1 is Pivotal for Intestinal Glucose Absorption and Glucose-Dependent Incretin Secretion
por: Gorboulev, Valentin, et al.
Publicado: (2012)

Xenin-25 Amplifies GIP-Mediated Insulin Secretion in Humans With Normal and Impaired Glucose Tolerance but Not Type 2 Diabetes
por: Wice, Burton M., et al.
Publicado: (2012)

Triglyceride Rich Lipoprotein -LPL-VLDL Receptor and Lp(a)-VLDL Receptor Pathways for Macrophage Foam Cell Formation
por: Takahashi, Sadao
Publicado: (2017)

Glucagon-like peptide-1 receptor agonists are not associated with retinal adverse events in the FDA Adverse Event Reporting System
por: Fadini, Gian Paolo, et al.
Publicado: (2018)

Hypothalamic Neuropeptide Y (NPY) Controls Hepatic VLDL-Triglyceride Secretion in Rats via the Sympathetic Nervous System
por: Bruinstroop, Eveline, et al.
Publicado: (2012)

Too Much Glucagon, Too Little Insulin: Time course of pancreatic islet dysfunction in new-onset type 1 diabetes
por: Brown, Rebecca J., et al.
Publicado: (2008)

Short-Term Hyperglycemic Dysregulation in Patients With Type 1 Diabetes Does Not Change Myocardial Triglyceride Content or Myocardial Function
por: Hammer, Sebastiaan, et al.
Publicado: (2008)

Apolipoprotein E content of VLDL limits LPL-mediated triglyceride hydrolysis
por: Whitacre, Brynne E., et al.
Publicado: (2021)

Plasma YKL-40: A BMI-Independent Marker of Type 2 Diabetes
por: Nielsen, Anders R., et al.
Publicado: (2008)

Gene-environment interactions due to quantile-specific heritability of triglyceride and VLDL concentrations
por: Williams, Paul T.
Publicado: (2020)

Proinsulin Secretion Is a Persistent Feature of Type 1 Diabetes
por: Sims, Emily K., et al.
Publicado: (2019)

Methylprednisolone Therapy in Acute Hemorrhagic Edema of Infancy
por: Risikesan, Jeyanthini, et al.
Publicado: (2014)

Successful Topical Treatment of Pigmented Purpuric Lichenoid Dermatitis of Gougerot-Blum in a Young Patient: A Case Report and Summary of the Most Common Pigmented Purpuric Dermatoses
por: Risikesan, Jeyanthini, et al.
Publicado: (2017)

A rare variant in APOC3 is associated with plasma triglyceride and VLDL levels in Europeans
por: Timpson, Nicholas J., et al.
Publicado: (2014)

Postprandial Peaking and Plateauing of Triglycerides and VLDL in Patients with Underlying Cardiovascular Diseases Despite Treatment
por: Samson, Clarissa E., et al.
Publicado: (2012)

Residual C-peptide secretion and hypoglycemia awareness in people with type 1 diabetes
por: Wellens, Martine J, et al.
Publicado: (2021)

Hepatic MDM2 Causes Metabolic Associated Fatty Liver Disease by Blocking Triglyceride‐VLDL Secretion via ApoB Degradation
por: Lin, Huige, et al.
Publicado: (2022)

Plasma Fetuin-A Levels and the Risk of Type 2 Diabetes
por: Stefan, Norbert, et al.
Publicado: (2008)

Distinct Monocyte Gene-Expression Profiles in Autoimmune Diabetes
por: Padmos, Roos C., et al.
Publicado: (2008)

Circulating Retinol-Binding Protein-4 Concentration Might Reflect Insulin Resistance–Associated Iron Overload
por: Fernández-Real, José Manuel, et al.
Publicado: (2008)

Novel De Novo Mutation in Sulfonylurea Receptor 1 Presenting as Hyperinsulinism in Infancy Followed by Overt Diabetes in Early Adolescence
por: Abdulhadi-Atwan, Maha, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_33b42r99svfu28k441v7skvi47